These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10978025)

  • 21. Importance of RNA secondary structure information for yeast donor and acceptor splice site predictions by neural networks.
    Marashi SA; Goodarzi H; Sadeghi M; Eslahchi C; Pezeshk H
    Comput Biol Chem; 2006 Feb; 30(1):50-7. PubMed ID: 16386465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Food allergy order in 16 pairs of brothers and 4 families].
    De Luca L; Chiummariello S
    Pediatr Med Chir; 1994; 16(1):53-7. PubMed ID: 8029090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of extemporaneously compounded slow-release capsules containing morphine sulfate or oxycodone hydrochloride.
    Glowiak DL; Green JL; Bowman BJ
    Int J Pharm Compd; 2005; 9(2):157-64. PubMed ID: 23924916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surrogate data modeling the relationship between high frequency amplitudes and Higuchi fractal dimension of EEG signals in anesthetized rats.
    Spasic S; Kalauzi A; Kesic S; Obradovic M; Saponjic J
    J Theor Biol; 2011 Nov; 289():160-6. PubMed ID: 21920374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of tuberculosis in patients with comorbidities].
    Abe M; Fujita A
    Kekkaku; 2013 Dec; 88(12):827-41. PubMed ID: 24551955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the formulation of sustained release potassium chloride tablets.
    Senel S; Capan Y; Hincal AA
    Pharmazie; 1991 Nov; 46(11):792-5. PubMed ID: 1811230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early amplification options.
    Gabbard SA; Schryer J
    Ment Retard Dev Disabil Res Rev; 2003; 9(4):236-42. PubMed ID: 14648816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and properties of modified chitosan as potential matrix materials for drug sustained-release beads.
    Ding P; Huang KL; Li GY; Liu YF
    Int J Biol Macromol; 2007 Jul; 41(2):125-31. PubMed ID: 17376525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparations of matrix tablets from a polyacrylate base].
    Mank R; Zessin G; Fahr F
    Pharmazie; 1986 Jan; 41(1):42-4. PubMed ID: 3960947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological study of ovarian embryonal carcinoma (Higuchi-Kato)].
    Tanaka Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1511-8. PubMed ID: 7130773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of drug release from matrix systems involving moving boundaries: approximate analytical solutions.
    Lee PI
    Int J Pharm; 2011 Oct; 418(1):18-27. PubMed ID: 21251957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yasuhara, yoshinaga, and higuchi reply:
    Yasuhara H; Yoshinaga S; Higuchi M
    Phys Rev Lett; 2000 Sep; 85(11):2411. PubMed ID: 10978025
    [No Abstract]   [Full Text] [Related]  

  • 33. Monte Carlo simulations and fractional kinetics considerations for the Higuchi equation.
    Dokoumetzidis A; Kosmidis K; Macheras P
    Int J Pharm; 2011 Oct; 418(1):100-3. PubMed ID: 21130148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higuchi equation: derivation, applications, use and misuse.
    Siepmann J; Peppas NA
    Int J Pharm; 2011 Oct; 418(1):6-12. PubMed ID: 21458553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mathematical method for quantitative expression of deviation from the higuchi model.
    Gohel MC; Panchal MK; Jogani VV
    AAPS PharmSciTech; 2000 Oct; 1(4):E31. PubMed ID: 14727896
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.